Search results
We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.
- Lilly Careers
Find your place at Lilly with Lilly Careers. For more than a...
- Investor Relations
The Investor Relations website contains information about...
- Annual Reports
Lilly.com. Search Lilly.com For Content... Annual Reports...
- Trials
Lilly is committed to the discovery, research and...
- Webcasts & Presentations
Speaker: Patrik Jonsson, Senior Vice President, President of...
- Who We Are
We’re a medicine company turning science into healing to...
- ESG Report
Lilly unites caring with discovery to create medicines that...
- Login
Connecting to Lilly. The following services are available to...
- Lilly Careers
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
Jun 25, 2024 · Find out the latest news, events, financial results, and ESG report of Eli Lilly and Company, a global biopharmaceutical company. Learn more about its clinical development pipeline and key ratios.
Learn more about clinical trials, and find out how you can be a research volunteer at Lilly Centre for Clinical Pharmacology.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
For more than 90 years, Lilly has been committed to diabetes and meeting the needs of people affected by diabetes with treatment options, support programs and more.
Recent Press Releases. View All Press Releases. Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease. July 2, 2024. Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria. June 25, 2024.
